文献速递免疫规划

单独或与不同基因型共接种GII.4病毒样颗粒诱导的诺如病毒特异性抗体和T细胞的功能性与亲和力

Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
PubMed 文献 · Vaccine · 2017-12-13

本研究在BALB/c小鼠中比较肌内或皮内注射GII.4病毒样颗粒单独或与GI及其他GII基因型病毒样颗粒共接种的免疫原性。结果显示肌内与皮内接种诱导相当的GII.4特异性抗体和T细胞应答,单价与不同基因型组合诱导的抗体和干扰素-γ产生T细胞应答的幅度与功能性相似,即使同时共接种多达五种不同诺如病毒病毒样颗粒基因型也未观察到免疫干扰。

要点

  • 肌内与皮内接种GII.4病毒样颗粒诱导相当的GII.4特异性抗体和T细胞应答。
  • 单价GII.4或不同基因型组合诱导的抗体和干扰素-γ产生T细胞应答幅度与功能性相似。
  • 同时共接种多达五种不同诺如病毒病毒样颗粒基因型未观察到免疫干扰。

核心结论

  • 即使同时共接种多达五种不同诺如病毒病毒样颗粒基因型也未观察到免疫干扰,未观察到诺如病毒特异性抗体功能性或T细胞应答的幅度、特异性和亲和力受抑制。

研究设计与样本

  • 在BALB/c小鼠中经肌内或皮内注射GII.4病毒样颗粒,单独或与GI及其他GII基因型病毒样颗粒共接种。

主要发现

  • 肌内和皮内接种诱导相当的GII.4特异性抗体和T细胞应答。
  • 单价GII.4病毒样颗粒或不同基因型组合诱导相似幅度和功能性的抗体及产生干扰素-γ的T细胞。
  • 使用多色流式细胞的脱颗粒试验首次显示诺如病毒GII.4特异性CD8+ T细胞具有细胞毒性T淋巴细胞表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Norovirus (NoV) is the main cause of acute gastroenteritis worldwide across all age groups. Current NoV vaccine candidates are based on non-infectious highly immunogenic virus-like particles (VLPs) produced in cell cultures in vitro. As NoVs infecting human population are highly divergent, it is proposed that the vaccine should contain at least two different NoV genotypes, potentially affecting the immunogenicity of each other. We investigated the immunogenicity of NoV GII.4 VLPs administered by intramuscular (IM) or intradermal (ID) injections to BALB/c mice either alone or co-delivered with genogroup I (GI) and other genogroup GII VLPs. Serum NoV-specific IgG binding antibody titers and antibody functionality in terms of avidity and blocking potential were assessed. Furthermore, the specificity and functional avidity of CD4+ and CD8+ T cell responses were analyzed using synthetic peptides previously identified to contain NoV VP1 P2 domain-specific H-2d epitopes. The results showed that IM and ID immunization induced comparable GII.4-specific antibodies and T cell responses. Similar magnitude and functionality of antibodies and interferon-gamma producing T cells were developed using monovalent GII.4 VLPs or different genotype combinations. For the first time, degranulation assay using multicolor flow cytometry showed that NoV GII.4-specific CD8+ T cells had cytotoxic T lymphocyte phenotype. To conclude, our results demonstrate that there is no immunological interference even if up to five different NoV VLP genotypes were co-administered at the same time. Furthermore, no inhibition of NoV-specific antibody functionality or the magnitude, specificity and affinity of T cell responses was observed in any of the immunized animals, observations relevant for the development of a multivalent NoV VLP vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Malm M, Tamminen K, Heinimäki S, et al. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes. Vaccine. 2017. PMID: 29246474. doi:10.1016/j.vaccine.2017.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。